Clinical, biochemical and molecular findings in a two-generation Morquio A family

Anna Tylki-Szymanska, Barbara Czartoryska, Susanna Bunge, Otto P. van Diggelen, Wim J. Kleijer, Ben J.H.M. Poorthuis, Jan G.M. Huijmans, Danuta Górska

Research output: Contribution to journalArticleAcademicpeer-review

21 Citations (Scopus)


Mucopolysaccharidosis type IVA (Morquio A) is caused by a deficiency of N-acetylgalactosamine-6-sulfatase (GALNS), an enzyme capable of cleaving the sulfate group from both N-acetylgalactosamine-6-sulfate and galactose-6-sulfate. We describe here a two-generation Morquio A family with two distinct clinical phenotypes. The two probands from the second generation showed intermediate signs of the disease whereas their affected mother, aunt and two uncles had only very mild symptoms. Galactose-6-sulfatase (GALS) activity in leukocytes and fibroblasts of the affected family members was clearly deficient. Molecular genetic analysis of the GALNS gene revealed that two different point mutations segregate in the family, which correlated well with the clinical phenotype. The probands with intermediate symptoms were compound heterozygotes for the mutations R259Q and R94G, the latter one being inherited from the unaffected father. The mother and her affected siblings with the unusually mild phenotype were proven to be homozygous for the novel missense point mutation R259Q.
Original languageEnglish
Pages (from-to)369-374
Number of pages6
JournalClinical Genetics
Issue number5
Publication statusPublished - May 1998

Bibliographical note

Copyright Munksgaard 1998

Research programs

  • EMC MGC-02-96-01


Dive into the research topics of 'Clinical, biochemical and molecular findings in a two-generation Morquio A family'. Together they form a unique fingerprint.

Cite this